Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands

被引：31

作者：

Ortega, Raquel ^{[1
]}

Ravina, Enrique ^{[1
]}

Masaguer, Christian F. ^{[1
]}

Areias, Filipe ^{[2
]}

Brea, Jose ^{[2
]}

Loza, Maria I. ^{[2
]}

Lopez, Laura ^{[3
]}

Selent, Jana ^{[3
]}

Pastor, Manuel ^{[3
]}

Sanz, Ferran ^{[3
]}

机构：

[1] Univ Santiago Compostela, Fac Farm, Dept Quim Organ, E-15782 Santiago De Compostela, Spain

[2] Univ Santiago Compostela, Fac Farm, Dept Farmacol, E-15782 Santiago De Compostela, Spain

[3] Univ Pompeu Fabra, IMIM, Res Unit Biomed Informat GRIB, E-08003 Barcelona, Spain

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 06期

关键词：

Dopamine receptors; Antipsychotics; Structure-activity relationship; Benzolactams; Arylpiperazines; SCHMIDT REACTION; SCHIZOPHRENIA; SELECTIVITY; ANTAGONISTS; INHIBITION; MODELS; DRUGS; 2ND;

D O I：

10.1016/j.bmcl.2009.01.067

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of new benzolactam derivatives was synthesized and the derivatives were evaluated for their affinities at the dopamine D-1, D-2, and D-3 receptors. Some of these compounds showed high D-2 and/or D-3 affinity and selectivity over the D-1 receptor. The SAR study of these compounds revealed structural characteristics that decisively influenced their D-2 and D-3 affinities. Structural models of the complexes between some of the most representative compounds of this series and the D-2 and D-3 receptors were obtained with the aim of rationalizing the observed experimental results. Moreover, selected compounds showed moderate binding affinity on 5-HT2A which could contribute to reducing the occurrence of extrapyramidal side effects as potential antipsychotics. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：1773 / 1778

页数：6

共 35 条

[1] Ballesteros J. A., 1995, METH NEUROSCI, P366, DOI [DOI 10.1016/S1043-9471, DOI 10.1016/S1043-9471(05)80049-7]
[2] Interactive SAR studies:: Rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists
Bettinetti, L
Schlotter, K
Hübner, H
Gmeiner, P
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (21) : 4594 - 4597
[3] Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
Bézard, E
Ferry, S
Mach, U
Stark, H
Leriche, L
Boraud, T
Gross, C
Sokoloff, P
[J]. NATURE MEDICINE, 2003, 9 (06) : 762 - 767
[4] Dopamine D3 receptor ligands - Recent advances in the control of subtype selectivity and intrinsic activity
Boeckler, Frank
Gmeiner, Peter
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2007, 1768 (04): : 871 - 887
[5] The structural evolution of dopamine D3 receptor ligands:: Structure-activity relationships and selected neuropharmacological aspects
Boeckler, Frank
Gmeiner, Peter
[J]. PHARMACOLOGY & THERAPEUTICS, 2006, 112 (01) : 281 - 333
[6] QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine
Brea, Jose
Castro, Marian
Loza, M. Isabel
Masaguer, Christian F.
Ravina, Enrique
Dezi, Cristina
Pastor, Manuel
Sanz, Ferran
Cabrero-Castel, Araceli
Galan-Rodriguez, Beatriz
Fernandez-Espejo, Emilio
Maldonado, Rafael
Robledo, Patricia
[J]. NEUROPHARMACOLOGY, 2006, 51 (02) : 251 - 262
[7] EFFECT OF SEROTONIN ANTAGONISM IN SCHIZOPHRENIA - A PILOT-STUDY WITH SETOPERONE
CEULEMANS, DLS
GELDERS, YG
HOPPENBROUWERS, MLJA
REYNTJENS, AJM
JANSSEN, PAJ
[J]. PSYCHOPHARMACOLOGY, 1985, 85 (03) : 329 - 332
[8] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9] SCHMIDT REACTIONS IN POLYPHOSPHORIC ACID .1. REARRANGEMENT OF KETONES
CONLEY, RT
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1958, 23 (09) : 1330 - 1333
[10] SCHMIDT REACTION WITH AROMATIC KETONES
EVANS, D
LOCKHART, IM
[J]. JOURNAL OF THE CHEMICAL SOCIETY, 1965, (SEP): : 4806 - &

← 1 2 3 4 →